Amgen
AMGN
2,091 hedge funds and large institutions have $107B invested in Amgen in 2020 Q2 according to their latest regulatory filings, with 169 funds opening new positions, 782 increasing their positions, 832 reducing their positions, and 90 closing their positions.
88% more first-time investments, than exits
New positions opened: 169 | Existing positions closed: 90
16% more capital invested
Capital invested by funds: $91.9B → $107B (+$14.9B)
3% more funds holding
Funds holding: 2,030 → 2,091 (+61)
0.01% more ownership
Funds ownership: 76.93% → 76.94% (+0.01%)
6% less repeat investments, than reductions
Existing positions increased: 782 | Existing positions reduced: 832
11% less funds holding in top 10
Funds holding in top 10: 119 → 106 (-13)
24% less call options, than puts
Call options by funds: $880M | Put options by funds: $1.16B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nordea Investment Management
Stockholm,
Sweden
|
+$892M |
| 2 |
JP Morgan Chase
New York
|
+$543M |
| 3 |
BlackRock
New York
|
+$517M |
| 4 |
ClearBridge Investments
New York
|
+$350M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$215M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$751M |
| 2 |
Renaissance Technologies
New York
|
-$488M |
| 3 |
Capital International Investors
Los Angeles,
California
|
-$363M |
| 4 |
Winslow Capital Management
Minneapolis,
Minnesota
|
-$302M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$198M |
AMGN Hedge Fund Activity: Q2 2020 in Review
2,091 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q2 2020, worth a combined $107B — up 16% from $91.9B a quarter earlier.
Buyers outnumbered sellers: 169 funds opened new AMGN positions and 90 closed out — a net gain of 79 holders — while 782 added to existing stakes and 832 trimmed.
The largest buyer was Nordea Investment Management, adding an estimated $892M. The largest seller was Loomis, Sayles & Company, cutting an estimated $751M.
- 2,091 institutional investors held Amgen (AMGN) as of Q2 2020, up from 2,030 in Q1 2020.
- Funds reported $107B of Amgen stock for Q2 2020, up 16% quarter-over-quarter.
- 169 funds opened new Amgen positions in Q2 2020 and 90 closed out, a net change of +79 holders.
- The largest Amgen buyer in Q2 2020 was Nordea Investment Management, an estimated $892M added.
- The largest Amgen seller in Q2 2020 was Loomis, Sayles & Company, an estimated $751M sold.
Based on aggregated 13F filings for Q2 2020.